Drug: infliximab Quarter: 2016Q3
Total Records: 643 Number of Pages: 33
| DRUGNAME | PT | EventCount |
|---|---|---|
| INFLIXIMAB HOSPIRA | Immunosuppression | 1 |
| INFLIXIMAB HOSPIRA | Inappropriate schedule of drug administration | 1 |
| INFLIXIMAB HOSPIRA | Inflammation | 1 |
| INFLIXIMAB HOSPIRA | Joint injury | 1 |
| INFLIXIMAB HOSPIRA | Joint swelling | 1 |
| INFLIXIMAB HOSPIRA | Malaise | 1 |
| INFLIXIMAB HOSPIRA | Musculoskeletal stiffness | 1 |
| INFLIXIMAB HOSPIRA | Nail disorder | 1 |
| INFLIXIMAB HOSPIRA | Neoplasm | 1 |
| INFLIXIMAB HOSPIRA | Nocardiosis | 1 |
| INFLIXIMAB HOSPIRA | Onychomycosis | 1 |
| INFLIXIMAB HOSPIRA | Oropharyngeal candidiasis | 1 |
| INFLIXIMAB HOSPIRA | Pain | 1 |
| INFLIXIMAB HOSPIRA | Pneumocystis jirovecii pneumonia | 1 |
| INFLIXIMAB HOSPIRA | Pneumonia bacterial | 1 |
| INFLIXIMAB HOSPIRA | Proteus infection | 1 |
| INFLIXIMAB HOSPIRA | Psoriatic arthropathy | 1 |
| INFLIXIMAB HOSPIRA | Respiratory tract infection bacterial | 1 |
| INFLIXIMAB HOSPIRA | Tenosynovitis | 1 |
| INFLIXIMAB HOSPIRA | Therapeutic response decreased | 1 |
Total Records: 643 Number of Pages: 33